Molecular Biology News: Breaking Molecular Biology News, Comments and Articles.

OMICS to Co-Publish Open Access Journals with AstonJournals

Henderson, NV, June 18, 2013 --(PR.com)-- OMICS Group Inc. (omicsonline.org) is pleased to announce the signing of co-partnership agreement. This latest arrangement establishes OMICS as co-Publisher with the AstonJournals, The announcement marks another step in the expansion of OMICS’s publishing partnerships with leading Publishers. The co-publishing agreement was signed between Dr. Srinu...

Using Altered Metabolic Pathways to Diagnose Alzheimers Disease

In previous notes, I have touched lightly on metabolomics but have not discussed the relevance of this science for clinical applications (see: Metabolomics, Metabolomic Profiling, and Systems Biology). A recent article made me more aware of some of t...

ACTIVAERO RECEIVES RESEARCH GRANT FOR DEVELOPMENT OF THERAPY AGAINST CHRONIC LUNG DISEASES

Activaero GmbH / ACTIVAERO RECEIVES RESEARCH GRANT FOR DEVELOPMENT OF THERAPY AGAINST CHRONIC LUNG DISEASES . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement. Munich m4 biotech cluster program extends support for the development of a novel method to treat chronic lung diseases   Program focuses on targeted treatment of...

Colleen’s Dream Foundation Gifts $10,000 to The University of Arizona Cancer Center to Support Early Ovarian Cancer Detection Research

Colleen’s Dream Foundation has made a $10,000 gift to the University of Arizona Cancer Center in an effort to support early ovarian cancer detection research, according to Colleen’s Dream Foundation President Billy Cundiff. Phoenix, AZ (PRWEB) June 18, 2013 In an ongoing effort to support research for early detection of ovarian cancer, Colleen’s Dream Foundation has made a $10,000 gift to T...

UCSC experts awarded $3.5M NIH grant to develop cancer genomics tools

Despite some successes, predicting cancer outcomes based on the molecular signatures in cancer cells remains a major challenge. A new effort, funded by the National Cancer Institute and led by researchers at the University of California, Santa Cruz,...

An end to chasing structures that were never there

Research describes a rapid computational method for identifying incorrect molecular structures that have been mistakenly determined using misassigned NMR signals. Ariel Sarotti, a scientist in Argentina, has developed a tool that combines calculated...

Bioinformatics Market Worth $7.5 Billion by 2017

DALLAS, June 18, 2013 /PRNewswire/ -- The "Bioinformatics Market By Sector (Molecular Medicine, Agriculture, Research & Forensic), Segment (Sequencing Platforms, Knowledge Management Tools & Data Analysis Services) & Application (Genomics, Proteomics & Drug Design) - Global Forecasts to 2017", analyzes and studies the Major Market Drivers, Restraints, and Opportunit...

FGF21 endocrine hormone which reduces glucose levels also protects against cardiac diseases in mice

A research group has found that FGF21, an endocrine factor which reduces glucose levels, protects against cardiac diseases in mice. The research, published online on the journal Nature Communications, was led by Francesc Villarroya, professor from th...

NuView Life Sciences Announces Presentation of Data for Novel Prostate and Bladder Cancer Molecular Diagnostic at SNMMI

VPAC1-based Urine Screen Identified Shed Cancer Cells in 100% of Prostate and Bladder Cancer Patients and none of Healthy or Benign Prostate Hyperplasia Patients in Translational Research Study Park City, UT (PRWEB) June 18, 2013 NuView Life Sciences (NLS), a privately held company developing next generation imaging and in vitro diagnostic (IVD) biomarkers, today announced the results from a tran...

WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data

The Centers for Medicare & Medicaid Services (CMS) released a final decision memorandum concluding that FDG Position Emission Tomography (PET) is nationally covered to guide subsequent management of anti-tumor strategy, and the agency ended the requirement for prospective data collection. Washington DC (PRWEB) June 18, 2013 On June 11, 2013 the Centers for Medicare & Medicaid Services...

PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System

PathoGenetix has hired John A. Luckey, Ph.D., M.B.A., as Vice President of Engineering, to lead product development and system integration for the RESOLUTION™ Microbial Genotyping System. The RESOLUTION System, which provides bacterial serotype and strain type information from complex mixtures in five hours, is currently in alpha testing, with beta testing of systems expected to commence in Q4 2...

Researcher studies protein's link to heart disease

(Medical Xpress)—The largest protein known to exist in the human body functions as a molecular spring, and University of Arizona researchers are gaining new insights into its role in heart disease.

Genomic instability in new molecular pathway may predict worse outcomes in breast cancer patients

A new molecular pathway involving the gene ZNF365 has been identified and abnormalities in that pathway may predict worse outcomes for patients with breast cancer, according to data published in Cancer Discovery, a journal of the American Association...

Moffitt Cancer Center Announces Strategic Partnership with Advinus Therapeutics

TAMPA, Fla. and BANGALORE, India, June 18, 2013 /PRNewswire/ -- Moffitt Cancer Center announced a strategic partnership with Advinus Therapeutics to advance its discoveries to the clinics. Two promising targeted cancer therapies (Rb:Raf-1 disruptor and ROCK inhibitor) developed by Moffitt scientists are selected as the first set.  The Rb:Raf-1 disruptor holds great clinical potential bec...

Scientists discover molecular pathway that can prevent death of oocytes due to chemotherapy

Young women who have cancer treatment often lose their fertility because chemotherapy and radiation can damage or kill their immature ovarian eggs, called oocytes. Now, Northwestern Medicine- scientists have found the molecular pathway that can preve...

Optimised system for preparation of Drosophila melanogaster (fly) food

Researchers at the Centro Biología Molecular Severo Ochoa (CBMSO) in Madrid, Spain have demonstrated how the MEDIACLAVE Media Preparator and the DOSE IT Peri­staltic Pump from INTEGRA are able to signifi­cantly en­hance the efficiency and re­produci­bility of fly food preparation. Drosophila melanogaster, the common fruit fly, is a commonly used model research organism...

DHT appoints Group Head of Science

The Dr Hadwen Trust for Humane Research (DHT) has appointed a senior scientist from Unilever to spearhead its ambition to replace the use of animals in medical research. Brett Cochrane, who has a PhD in molecular microbiology and more than six years’ post-doctoral experience within Unilever’s Safety and Environmental Assurance Centre, helped drive Unilever’s efforts to identify a...

Drug-Resistant Prostate Cancer Treated With New Medication In The Laboratory

A new drug called pyrvinium pamoate inhibits aggressive forms of prostate cancer that are resistant to standard drugs, according to a study conducted in an animal model. The results were presented at The Endocrine Society's 95th Annual Meeting in San...

Chemically inducible diffusion trap at cilia reveals molecular sieve–like barrier

Post-translational modifications: Panning for phosphohistidine

Elusive pan-phosphohistidine (pHis) antibodies have been generated using a hydrolytically stable triazolyl-phosphonate hapten, promising to substantially accelerate efforts to better understand the role of pHis in biology.

Structural biology: FaPy lesions and DNA mutations

Formamidopyrimidine residues are damaged purines that retain the same Watson-Crick hydrogen-bonding face found in the parent nucleobase, yet these lesions are mutagenic. Crystallographic evidence suggests molecular mechanisms by which these lesions '...

Cell biology: Viruses get an ESCRT

Discovery Of Source Of Tumor Growth In Aggressive Prostate Cancer

Researchers have discovered a molecular switch that explains, at least in part, how some fast-growing prostate cancers become resistant to hormone treatment, a new study conducted in human cell cultures and mice finds. The results were presented at T...

MDxHealth Announces Changes to Its Board of Directors

IRVINE, CA and LIEGE, BELGIUM -- (Marketwired) -- 06/18/13 -- MDxHealth SA (EURONEXT BRUSSELS: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today announced changes to the composition of its Board of Directors, including the election of Dr. Rudi Pauwels, PhD, as an independent director. The company also announced that...

Process Of Metastasis Explained By 'Chase And Run' Cell Movement Mechanism

A mechanism that cells use to group together and move around the body - called 'chase and run' - has been described for the first time by scientists at UCL. Published in Nature Cell Biology, the new study focuses on the process that occurs when cance...